Redmile Group
Overview
Redmile Group is a private investment firm founded in 2007 that focuses on investments in the healthcare and life sciences sectors, including biotechnology and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BioNTech SE | Jul 2019 | Series B | Co-investor |
| Virta Health | Mar 2017 | Series A | Lead |
| PAX Labs | Apr 2019 | Growth Equity | Co-investor |
| Verve | Jan 2021 | Series B | Co-investor |
| thriveworks | Jul 2021 | Private Equity | Co-investor |
For institutional investors. Book with your work email.
Key People
Rob Faulkner
Managing Director
Florian Reinaud
Venture Partner
Gerardo Galvan
Commercial Investment Partner Honorary Director Of Audit And Risk Committee (semi-retired)
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Redmile Group based?
Redmile Group is headquartered in San Francisco, California, United States.
When was Redmile Group founded?
Redmile Group was founded in 2007.
How many portfolio companies does Redmile Group have?
Redmile Group has 50 portfolio companies in Caplight's dataset.
What are some companies in Redmile Group's portfolio?
Portfolio companies visible on Caplight include BioNTech SE, Virta Health, PAX Labs, Verve, thriveworks.
What was Redmile Group's most recent investment shown here?
Redmile Group's most recent investment in this portfolio sample was in thriveworks in 2021.
What sectors does Redmile Group focus on?
Redmile Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Redmile Group focus on?
Redmile Group typically invests at the MultiStage stage.
What is Redmile Group's AUM?
Redmile Group's assets under management are estimated between $1.0B and $10.0B.